The rancorous debate in the United States over the healthcare reform has finally come to an end with passing of the landmark healthcare bill. It aims to lower the overall cost of healthcare and increase the quality of healthcare for all US citizens.Healthcare payers in all markets continue to endeavor pricing pressure on pharmaceutical companies to reduce costs. Bringing you the latest updates in pharmaceutical pricing and reimbursement from leading experts in Europe and the US who will present the best approaches in overcoming barriers to implementation of market access, and revealing most effective pricing strategies.Visiongain is honored to present its 9th Annual Pricing and Reimbursement Conference which will not only provide you with an opportunity to understand the growing importance of payers/restructuring of pharma marketing and sales to align with these changes but also examine unique P&R strategies for Japan.You will gain an insight into the 2010 reforms and an evolving regulatory landscape helping you to make successful pricing and reimbursement decisions, to maximise profit and maintain market share.